KEMRI-Wellcome Research Programme
The KEMRI-Wellcome Research Programme is a collaborative research programme between the Wellcome Trust and the Kenyan Medical Research Institute (KEMRI). Their aim is to inform the delivery of healthcare within existing African structures, oriented by local priorities and relying on local scientists. Areas of their work include malaria in clinical studies, parasitology and public health, as well as genetic, clinical and immune-response epidemiology.
The Programme is located at two sites in Kenya - in Kilifi, an hour's drive north of Mombasa on the coast, and in the capital, Nairobi (part of the Kenya Medical Research Institute [KEMRI] Centre for Geographic Medicine Research, Coast). The laboratories in Kilifi are connected to the District Hospital.
- Kevin Marsh (MalariaGEN Investigator)
- Tom Williams (MalariaGEN Investigator)
- Norbert Peshu (MalariaGEN Investigator)
- Gilbert Kokwaro (MalariaGEN Investigator)
- Carolyne Ndila (MalariGEN Data Fellow)
How the team are contributing to MalariaGEN
The KEMRI-Wellcome Research Programme is contributing samples to Consortial Project 1, Consortial Project 2 and Consortial Project 3.
For Consortial Project 1 the team in Kilifi have recruited a pool of 2300 new severe malaria cases and 12,000 cord blood controls from which MalariaGEN samples will be selected. For Consortial Project 2 the team are contributing 1200 samples from an ongoing longitudinal study.
The team in Nairobi have collected six sets of 33 trios for Consortial Project 3 from different ethnic groups around Kenya.